$ENZ News
Last published 1y ago
- 1y agoENZEnzo Biochem, Inc - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoENZENZBEnzo Biochem Reports Third Quarter Fiscal Year 2025 ResultsGlobeNewswireFARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX:ENZB) ("Enzo" or the "Company") today announced financial results for the fiscal third quarter ended April 30, 2025. Financial Highlights
- 1y agoENZENZBEnzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential TransactionGlobeNewswireForms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining
- 1y agoENZEnzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQXGlobeNewswireFARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced its intention to voluntarily delist its common stock from The New York Stock Exchange
- 1y agoENZEnzo Biochem Reports Second Quarter Fiscal Year 2025 ResultsGlobeNewswireFARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential
- 1y agoENZEnzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing RulesGlobeNewswireFARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced that it was notified by the New York Stock Exchange (the "NYSE") that it is not in compliance
- 1y agoENZEnzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company UpdateGlobeNewswireFARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal first quarter ended October 31, 2024. First Quarter
- 2y agoENZEnzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendGlobeNewswireFARMINGDALE, N.Y., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal fourth quarter ended July 31, 2024 and the fiscal year ended
- 2y agoENZEnzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateGlobeNewswireFARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal third quarter ended April 30, 2024. Third Quarter
- 2y agoENZEnzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateGlobeNewswireFARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the second quarter ended January 31, 2024. Second Quarter
- 2y agoENZEnzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer AppointmentsGlobeNewswireFARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024
- 2y agoENZENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATEGlobeNewswireFARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the first quarter ended October 31, 2023. First Quarter
- 3y agoENZENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATEGlobeNewswireFARMINGDALE, NY, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the fourth quarter ended July 31, 2023, and the fiscal year ended July
- 3y agoENZSteven J. Pully Appointed to Enzo Biochem's Board of DirectorsGlobeNewswireFARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or "the Company"), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company's
- 3y agoDSAQENZFARMFTLF+5The Radoff-Sudbury Group Files Definitive Proxy and Issues Letter to LifeVantage Corporation StockholdersBusiness WireHighlights the Destruction of 70% in Stockholder Value Under Garry Mauro's 10-Year Reign as Chairman Notes the Radoff-Sudbury Group's Aligned and Highly Qualified Director Candidates Collectively Own Significantly
- 3y agoENZEnzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEOGlobeNewswireFARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing
- 3y agoENZLHEnzo Biochem Completes Sale of Clinical Laboratory to LabcorpGlobeNewswireSignificant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a
- 3y agoENZEnzo Biochem Reports Third Quarter Fiscal Year 2023 Financial ResultsGlobeNewswire- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and diagnostics
- 3y agoENZFederman & Sherwood Investigates Enzo Biochem for Data BreachBusiness WireThe law firm of Federman & Sherwood has initiated an investigation into Enzo Biochem with respect to their recent data breach. On May 30, 2023, Enzo Biochem notified 2.47 million patients that the company
- 3y agoENZEnzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset SaleGlobeNewswireFARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that the preliminary voting results from the Inspector of Election at today's Special Meeting of the Shareholders
- 3y agoENZEnzo Biochem, Inc. Announces Date of Special Meeting of ShareholdersGlobeNewswireFARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo Biochem" or the "Company"), a leading biosciences and diagnostics company, today announced that its special meeting of
- 3y agoENZEnzo Biochem Reports Second Quarter Fiscal Year 2023 Financial ResultsGlobeNewswire- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division - Enzo Life Sciences reports revenue of $7.5 million, with Jan-23 revenue of $3.6M as the
- 3y agoENZLHEnzo Biochem Agrees to Sell Clinical Laboratory to LabcorpGlobeNewswireSignificant value unlocked for Enzo shareholders with continued focus on remaining businesses. FARMINGDALE, NY, March 16, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) announced today that it has
- 3y agoENZEnzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business UpdateGlobeNewswire- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic alternatives for the
- 3y agoENZEnzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12thGlobeNewswireConference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced
- 4y agoENZEnzo Biochem, Inc. Announces Date of Annual Shareholders' MeetingGlobeNewswireNEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced that its Annual Shareholders' Meeting will be held
- 4y agoEGYENZFARMHHS+2Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NWGlobeNewswireNORTHLAKE, Texas, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ:FARM) (the "Company"), today announced it has entered into a cooperation agreement (the "Cooperation Agreement") with JCP Investment
- 4y agoENZEnzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFOGlobeNewswireNEW YORK, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced the appointment of Patricia Eckert, CPA, as
- 4y agoENZEnzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business UpdateGlobeNewswire- Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022, net of FX - Company successfully launched AMPIVIEW™ gene expression platform powered by LoopRNA™ ISH technology
- 4y agoENZEnzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14thGlobeNewswireConference Call and Webcast Scheduled for October 14, 2022, 8:30 am ET NEW YORK, NY, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced
- 4y agoENZEnzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2GlobeNewswireNEW YORK, NY, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced the launch of the AMPIVIEW™ line, a breakthrough RNA gene expression platform pow
- 4y agoENZEnzo Biochem to Launch Monkeypox Testing Services this WeekGlobeNewswireNEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, announced today that its full-service clinical laboratory will begin accepting specimens for monkeyp
- 4y agoENZEnzo Biochem Appoints Matthew Kupferberg as General CounselGlobeNewswireNEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced the addition of Matthew Kupferberg as the Company's in-house General Counsel.
- 4y agoENZEnzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial AdvisorGlobeNewswireThird quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic shutdowns in Asia Received approval from New York State Department of Health for its AMPIPROBE® HPV Mol
- 4y agoENZUPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9thGlobeNewswireNEW YORK, NY, June 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2022 financial results on Thursday, June 9, 2022, after the market close. Th
- 4y agoENZEnzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9thGlobeNewswireConference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET NEW YORK, NY, June 02, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter
- 4y agoENZEnzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic TestGlobeNewswireNEW YORK, NY, April 19, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, announced that it has received approval from the New York State Department of Health (DOH) for its
- 4y agoENZEnzo Biochem Reports Results of its Annual Meeting of ShareholdersGlobeNewswireFOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, announced the approval of all proposals pre
- 4y agoENZEnzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on ProposalGlobeNewswireMeeting Scheduled for April 8, 2022 at 9:00 AM ET NEW YORK, NY, April 06, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, held its Annual Shareholder Meeting (the "An
- 4y agoENZEnzo Biochem Appoints David Bench and Kara Cannon to New Executive Management PositionsGlobeNewswireNEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced two key appointments to its new management structure. The Company announced Kara Ca
- 4y agoENZEnzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate UpdatesGlobeNewswireSecond quarter revenue of $34.0 million increased 28% sequentially and 8% year-over-year compared to FY2021 Enzo Biochem posted highest quarterly revenue in history of the Company Enzo Life Science revenue reached $10.4 million, an increase of 39%
- 4y agoENZEnzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor ForumGlobeNewswireNEW YORK, NY, March 10, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum, Tuesday,
- 4y agoENZEnzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14thGlobeNewswireConference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report second quarter 2
- 4y agoEGYENZHHSSPRT+1Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem's Board of DirectorsGlobeNewswireNEW YORK, NY, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, today announced the appointments of Hamid Erfanian and Bradley Radoff to the Company's Board of Dir
- 4y agoENZEnzo Biochem Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewswire1Q FY 2022 revenues of $26.5 million vs. $24.8 million in 4Q FY 2021, representing a 7% sequential increase Company appoints Hamid Erfanian as Chief Executive Officer Consolidated manufacturing footprint at state-of-the-art Farmingdale, NY campus to
- 4y agoENZEnzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15thGlobeNewswireConference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET NEW YORK, NY, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report f
- 5y agoENZENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICERGlobeNewswireNEW YORK, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company"), a leading biosciences and diagnostics company, announced today that on November 8, 2021, it granted equity awards to Hamid Erfanian. Consistent wit
- 5y agoENZBradley L. Radoff Issues Letter to the Independent Directors of Enzo Biochem Regarding Their Unwillingness to Acknowledge or Address Unprecedented Shareholder UnrestBusiness WireExpresses Disappointment with Independent Directors' Hollow and Tone-Deaf Response to a Top 5 Shareholder's Articulated Concerns and Offer to Pursue a Cooperation Agreement Questions Whether Recently-Appointed Directors Dr. Mary Tagliaferri and Dr. I
- 5y agoENZEnzo Biochem Expands GoTestMeNow™ Online Portal to Provide Patients with Direct Access to Private Testing for Sexually Transmitted InfectionsGlobeNewswireGoTestMeNow™ enables individuals to instantly and privately access physician-authorized testing for a broad range of STIs including chlamydia, gonorrhea, syphilis, HIV-1/2, hepatitis and herpes Expanded menu addresses increased patient
- 5y agoEGYENZHRTHSPRT+2Bradley L. Radoff Issues Open Letter to Recently-Appointed Independent Directors of Enzo BiochemBusiness WireAsserts the Company's Chief Executive Officer Succession Plan Further Entrenches Dr. Elazar Rabbani, who Will Continue Serving as Chairman and Chief Scientific Officer, Despite Unprecedented Shareholder Opposition and Unrest Calls on the Board to Tak